Yaky Yanay
2022
In 2022, Yaky Yanay earned a total compensation of $1.3M as Chief Executive Officer at Pluristem Therapeutics, a 86% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $64,000 |
|---|---|
| Salary | $488,569 |
| Other | $745,610 |
| Total | $1,297,726 |
Yanay received $745.6K in other compensation, accounting for 57% of the total pay in 2022.
Yanay also received $64K in non-equity incentive plan and $488.6K in salary.
Rankings
In 2022, Yaky Yanay's compensation ranked 2,528th out of 5,760 executives tracked by ExecPay. In other words, Yanay earned more than 56.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,528 out of 5,760 | 56th |
Division Manufacturing | 1,392 out of 3,136 | 56th |
Major group Chemicals And Allied Products | 630 out of 1,422 | 56th |
Industry group Drugs | 584 out of 1,323 | 56th |
Industry Biological Products, Except Diagnostic Substances | 146 out of 291 | 50th |
Source: SEC filing on February 27, 2023.
Yanay's colleagues
We found two more compensation records of executives who worked with Yaky Yanay at Pluristem Therapeutics in 2022.
News
Pluristem Therapeutics CEO Yaky Yanay's 2023 pay jumps 111% to $2.7M
May 1, 2024
Pluristem Therapeutics CEO Yaky Yanay's 2022 pay falls 86% to $1.3M
February 27, 2023
Pluristem Therapeutics Chairman Zami Aberman's 2020 pay falls 54% to $501K
April 8, 2021
Pluristem Therapeutics Chairman Zami Aberman's 2019 pay jumps 85% to $1.1M
May 20, 2020
Pluristem Therapeutics CEO Zami Aberman's 2018 pay falls 83% to $593K
April 25, 2019